RxDoctor Payments Data

Molly Berglund, APRN

Family · Athens, GANPI 1518390012

Payments from drug & device makers

$675in general payments, 2019–2025

Across 35 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$84
  • Exact Sciences$80
  • Sanofi-aventis U.S. LLC$77
  • Eisai Inc.$66
  • Edwards Lifesciences$60
  • Corcept Therapeutics$58
  • plus $251 from 7 others

What the payments were for

  • Food & beverage$675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$675 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$12,019
Medicare patients
55
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin12$40,541
EliquisApixaban14$23,481
JardianceEmpagliflozin22$20,341
FarxigaDapagliflozin Propanediol12$19,183
MounjaroTirzepatide14$15,411
Venlafaxine Hcl ErVenlafaxine Hcl20$2,382
Albuterol Sulfate HfaAlbuterol Sulfate60$1,961
Atorvastatin Calcium127$1,065
Omeprazole62$813
Rosuvastatin Calcium108$801
Diltiazem 24hr Er (Cd)Diltiazem Hcl24$727
Tamsulosin Hcl27$704
Gabapentin40$632
Amlodipine Besylate131$625
Pantoprazole Sodium48$594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$84$19,18312 claims
Lilly USA, LLCMounjaro$50$15,41114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →